Tag: thrombotic events
-
Andexxa Drug Recall December 2025 Due In Part To Safety Issue That Involves Blood Clots
High Rate Of Thrombotic Events And More Thrombosis-related Deaths Compared To Standard Antidote Treatment (Posted by Tom Lamb at Drug Injury Watch) UPDATE: Andexxa FDA Safety Communication Issued In December 2025 “Based on available data, the serious…
-
Possible Andexxa Recall After FDA Does Not Approve the Anticoagulant Reversal Drug in December 2024
AstraZeneca Says “while discussions with the FDA are ongoing, Andexxa will remain on the US market.” (Posted by Tom Lamb at Drug Injury Watch) In our November 21, 2024, article, “Do Andexxa Risks Outweigh Benefits Given Increased…